Skip to main content

How to start making hand sanitiser formula

12th June 2020

Submitted by:

Andrew Warmington

Dr Russel Walters, freelance scientist at Kolabtree, shares his expertise on how to start manufacturing a hand sanitiser quickly, easily and compliantly

In order for a virus to infect a human host, the host needs to be exposed to a sufficient viral load, typically hundreds, thousands or tens of thousands of viral particles. Hand sanitisers dramatically reduce the viral load on the skin and therefore can reduce infections or perhaps infection severity.

Sustained exposure is to an infected person is the commonest route of transmission. It is therefore important to sanitise the hands, because they are the primary contact with the outside world and can spread viral particles if they touch the eyes, mouth, food, etc.

Hand sanitisers have repeatedly been shown to slow the spread of viruses. They are regulated in most countries, but recently, due to Covid-19, manufacturing rules have been liberalised, including by the US FDA.

This opens a legal path for new manufacturers to expand into hand sanitiser supply and it also makes formulation straightforward. Unlike with skin lotions, the options are few and the constraints are clear.

Ingredients

In March, the FDA issued guidance for expanded production of hand sanitisers during the Covid-19 pandemic. The intention was to increase production by allowing more entities to manufacture them beyond previously licensed or registered drug manufacturers. However, the guidance is still very specific on the formulation of hand sanitisers. Two formulae have been allowed, based on either ethanol or isopropanol.

The World Health Organisation (WHO) has released an excellent step-by-step guide to the local production of hand sanitisers based on these same two formula options. The proportion of ingredients is also specified in volume %, but be aware of the difference between this and weight %. Different ingredients have different densities. While water has a density of 1g/cm3, for example, ethanol’s is 0.789g/cm3.

Both formulae contain 1.45% glycerin, and 0.125% hydrogen peroxide but ethanol makes up 80% of one formula, isopropanol 75% of the other. The remainder in both cases is sterile water. Note that most raw materials are not supplied as 100% pure, single ingredients; they often contain some water. Ethanol is typically sourced as 95%/5% ethanol/water, or 190 proof. You need to factor the raw material composition into your calculations.

Users tend to like fragrances in skin care products, but in hand sanitisers these ingredients are not needed and will increase the raw material prices of your product; plus, their base odour is minimal.  Under the FDA guidance, fragrances and skin benefit ingredients are explicitly not allowed in Covid-19 sanitisers.

Hand sanitiser gels, like Purell, use polymers to increase their viscosity, which can add some significant complications in the manufacturing process.  Thickening polymers are not part of the FDA formulae, but you may want to read more about the different polymeric options for thickening a water/alcohol solution — the two simple formulae will be water-thin and easily sprayable.

Further considerations

Boiling is the easiest and most likely source of sterile water — just be careful of heating and boiling water near the high proof, flammable alcohol. There are a few sources of ethanol, but it must be denatured to avoid consumption.

Mixing hand sanitiser is pretty straightforward, with one caveat: passivation. If you are using a glass or fibreglass vessel to mix your hand sanitiser, passivation is not a concern. However, if you are using a metal vessel, you will need to be aware that, in the presence of metal ions from the vessel, the hydrogen peroxide rapidly breaks down to water and oxygen.

Ensuring that the alcohol evaporation is limited between production and use is an important consideration. The packaging must seal sufficiently. Manual pumps are explicitly allowed in the FDA guidance.

Ethanol is a natural product. There are natural antimicrobials but efficacy data on them is limited and, more importantly, hand sanitisers are a regulated product. In order to label and market a product as a hand sanitiser, the FDA guidelines must be met.  

Hand sanitisers are probably better for the skin barrier than repeated washing with soap. Cleansing with soap often removes skin components and can disrupt the natural structure of the skin, whereas the alcohol in hand sanitisers rapidly evaporates and has little impact on the skin barrier. The core of your formula should therefore not cause any skin problems — fragrance is often the source of skin irritation, especially allergenic response.

Many problems are solved if you are following the FDA guidance on hand sanitisers and there is no need to test the bug-killing efficacy of your formula. Hand sanitisers with the formulae outlined above are well proven to effectively kill bugs and be safe for the user. You will simply need to check that after production, the alcohol level — ethanol or isopropyl alcohol — is checked by physical chemistry means, such as an alcoholmeter or a hydrometer.

Contact:

Jonathan Hedger

Kolabtree

+44 7956 259559

[email protected]

www.kolabtree.com

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington